PRPH Valuation

Prophase Labs Inc

Add to Watchlist

Advanced Chart

0.312

-0.014(-4.293%)1D

Overview
Forecast
Valuation
Earnings

PRPH Relative Valuation

PRPH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PRPH is overvalued; if below, it's undervalued.

Historical Valuation

Prophase Labs Inc (PRPH) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.50 is considered Undervalued compared with the five-year average of -36.67. The fair price of Prophase Labs Inc (PRPH) is between 3.81 to 5.08 according to relative valuation methord. Compared to the current price of 0.31 USD , Prophase Labs Inc is Undervalued By 91.81%.

Relative Value

Fair Zone

3.81-5.08

Current Price：0.31

91.81%

Undervalued

0.00

Trailing

Forward

0.00

EV/EBITDA

Prophase Labs Inc. (PRPH) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 1.47. The thresholds are as follows: Strongly Undervalued below -42.82, Undervalued between -42.82 and -20.68, Fairly Valued between 23.61 and -20.68, Overvalued between 23.61 and 45.76, and Strongly Overvalued above 45.76. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-4.09

EV/EBIT

Prophase Labs Inc. (PRPH) has a current EV/EBIT of -4.09. The 5-year average EV/EBIT is 3.85. The thresholds are as follows: Strongly Undervalued below -49.35, Undervalued between -49.35 and -22.75, Fairly Valued between 30.45 and -22.75, Overvalued between 30.45 and 57.04, and Strongly Overvalued above 57.04. The current Forward EV/EBIT of -4.09 falls within the Historic Trend Line -Fairly Valued range.

0.50

Prophase Labs Inc. (PRPH) has a current PS of 0.50. The 5-year average PS is 1.87. The thresholds are as follows: Strongly Undervalued below -0.66, Undervalued between -0.66 and 0.61, Fairly Valued between 3.13 and 0.61, Overvalued between 3.13 and 4.40, and Strongly Overvalued above 4.40. The current Forward PS of 0.50 falls within the Undervalued range.

0.00

P/OCF

Prophase Labs Inc. (PRPH) has a current P/OCF of 0.00. The 5-year average P/OCF is -6.49. The thresholds are as follows: Strongly Undervalued below -38.30, Undervalued between -38.30 and -22.39, Fairly Valued between 9.42 and -22.39, Overvalued between 9.42 and 25.33, and Strongly Overvalued above 25.33. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Prophase Labs Inc. (PRPH) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

Prophase Labs Inc (PRPH) has a current Price-to-Book (P/B) ratio of 0.90. Compared to its 3-year average P/B ratio of 1.61 , the current P/B ratio is approximately -44.34% higher. Relative to its 5-year average P/B ratio of 2.56, the current P/B ratio is about -65.02% higher. Prophase Labs Inc (PRPH) has a Forward Free Cash Flow (FCF) yield of approximately -120.31%. Compared to its 3-year average FCF yield of -36.33%, the current FCF yield is approximately 231.14% lower. Relative to its 5-year average FCF yield of -24.65% , the current FCF yield is about 388.00% lower.

0.90

P/B

Median3y

1.61

Median5y

2.56

-120.31

FCF Yield

Median3y

-36.33

Median5y

-24.65

Competitors Valuation Multiple

The average P/S ratio for PRPH's competitors is 24.29, providing a benchmark for relative valuation. Prophase Labs Inc Corp (PRPH) exhibits a P/S ratio of 0.50, which is -97.95% above the industry average. Given its robust revenue growth of -39.26%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Aspire Biopharma Holdings Inc

Performance Decomposition

Market capitalization of PRPH decreased by 88.39% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -234.47 to -326.90.

The secondary factor is the Revenue Growth, contributed -39.26%to the performance.

Overall, the performance of PRPH in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-39.26%

2.36M → 1.43M

Revenue Growth

39.42%

-234.47 → -326.90

Margin Expansion

-88.55%

-1.45 → -0.17

P/E Change

-88.39%